152 related articles for article (PubMed ID: 1346009)
1. Loss of heterozygosity on chromosome 7q and aggressive primary breast cancer.
Bièche I; Champème MH; Matifas F; Hacène K; Callahan R; Lidereau R
Lancet; 1992 Jan; 339(8786):139-43. PubMed ID: 1346009
[TBL] [Abstract][Full Text] [Related]
2. Loss of heterozygosity of the L-myc oncogene in human breast tumors.
Bieche I; Champeme MH; Merlo G; Larsen CJ; Callahan R; Lidereau R
Hum Genet; 1990 Jun; 85(1):101-5. PubMed ID: 1972691
[TBL] [Abstract][Full Text] [Related]
3. Loss of heterozygosity on 7q31 occurs early during breast tumorigenesis.
Champème MH; Bièche I; Beuzelin M; Lidereau R
Genes Chromosomes Cancer; 1995 Apr; 12(4):304-6. PubMed ID: 7539286
[TBL] [Abstract][Full Text] [Related]
4. Allelic loss on distal chromosome 17p is associated with poor prognosis in a group of Brazilian breast cancer patients.
Nagai MA; Pacheco MM; Brentani MM; Marques LA; Brentani RR; Ponder BA; Mulligan LM
Br J Cancer; 1994 Apr; 69(4):754-8. PubMed ID: 7908218
[TBL] [Abstract][Full Text] [Related]
5. (C-A)n microsatellite repeat D7S522 is the most commonly deleted region in human primary breast cancer.
Zenklusen JC; Bièche I; Lidereau R; Conti CJ
Proc Natl Acad Sci U S A; 1994 Dec; 91(25):12155-8. PubMed ID: 7991599
[TBL] [Abstract][Full Text] [Related]
6. Genetic alteration mapping on chromosome 7 in primary breast cancer.
Bièche I; Khodja A; Driouch K; Lidereau R
Clin Cancer Res; 1997 Jun; 3(6):1009-16. PubMed ID: 9815778
[TBL] [Abstract][Full Text] [Related]
7. [Loss of heterozygosity at different chromosomes in patients with breast cancer].
Deng GR; He LW; Lin BY
Zhonghua Yi Xue Za Zhi; 1994 Jan; 74(1):31-4, 63-4. PubMed ID: 7913405
[TBL] [Abstract][Full Text] [Related]
8. Genetic alterations on chromosome 17 in human breast cancer: relationships to clinical features and DNA ploidy.
Watatani M; Nagayama K; Imanishi Y; Kurooka K; Wada T; Inui H; Hirai K; Ozaki M; Yasutomi M
Breast Cancer Res Treat; 1993 Dec; 28(3):231-9. PubMed ID: 7912561
[TBL] [Abstract][Full Text] [Related]
9. Human breast cancer: genetic alterations in the MET gene region.
Tougas L; Halwani F; Tremblay G; Sampalis J; Lin J; Park M; Jothy S
Clin Invest Med; 1996 Aug; 19(4):222-30. PubMed ID: 8853570
[TBL] [Abstract][Full Text] [Related]
10. Loss of heterozygosity on chromosome 7q31 in breast cancer.
Cooke A; Kim YT; Harvey TI; Connor JM; Nagy J; George WD
Lancet; 1993 May; 341(8855):1289. PubMed ID: 8098436
[No Abstract] [Full Text] [Related]
11. Allelotype of breast cancer: cumulative allele losses promote tumor progression in primary breast cancer.
Sato T; Tanigami A; Yamakawa K; Akiyama F; Kasumi F; Sakamoto G; Nakamura Y
Cancer Res; 1990 Nov; 50(22):7184-9. PubMed ID: 1977515
[TBL] [Abstract][Full Text] [Related]
12. Loss of heterozygosity at 7q31 in breast cancer: results from an International Collaborative Study Group. The Breast Cancer Somatic Genetics Consortium.
Devilee P; Hermans J; Eyfjörd J; Bøorresen AL; Lidereau R; Sobol H; Borg A; Cleton-Jansen AM; Oláh E; Cohen BB; Scherneck S; Hamann U; Peterlin B; Caligo M; Bignon YJ; Maugard C
Genes Chromosomes Cancer; 1997 Mar; 18(3):193-9. PubMed ID: 9071572
[TBL] [Abstract][Full Text] [Related]
13. Evidence implicating at least two genes on chromosome 17p in breast carcinogenesis.
Coles C; Thompson AM; Elder PA; Cohen BB; Mackenzie IM; Cranston G; Chetty U; Mackay J; Macdonald M; Nakamura Y
Lancet; 1990 Sep; 336(8718):761-3. PubMed ID: 1976143
[TBL] [Abstract][Full Text] [Related]
14. Loss of heterozygosity at selective sites on chromosomes 13 and 17 in human breast carcinoma.
Thorlacius S; Jonasdottir O; Eyfjord JE
Anticancer Res; 1991; 11(4):1501-7. PubMed ID: 1746906
[TBL] [Abstract][Full Text] [Related]
15. Detailed deletion mapping with a refined physical map of 7q31 localizes a putative tumor suppressor gene for breast cancer in the region of MET.
Lin JC; Scherer SW; Tougas L; Traverso G; Tsui LC; Andrulis IL; Jothy S; Park M
Oncogene; 1996 Nov; 13(9):2001-8. PubMed ID: 8934547
[TBL] [Abstract][Full Text] [Related]
16. Loss of heterozygosity at chromosome 7q in human breast cancer: association with clinical variables.
Kristjansson AK; Eiriksdottir G; Ragnarsson G; Sigurdsson A; Gudmundsson J; Barkardottir RB; Jonasson JG; Egilsson V; Ingvarsson S
Anticancer Res; 1997; 17(1A):93-8. PubMed ID: 9066635
[TBL] [Abstract][Full Text] [Related]
17. [A new marker of aggressivity of breast cancers: loss of heterozygote on chromosome 7q].
Bièche I; Champème MH; Matifas F; Hacène K; Lidereau R
Bull Cancer; 1992; 79(9):865-72. PubMed ID: 1486222
[TBL] [Abstract][Full Text] [Related]
18. Initiation of bladder cancer may involve deletion of a tumour-suppressor gene on chromosome 9.
Cairns P; Shaw ME; Knowles MA
Oncogene; 1993 Apr; 8(4):1083-5. PubMed ID: 8096074
[TBL] [Abstract][Full Text] [Related]
19. A molecular cytogenetic analysis of 7q31 in prostate cancer.
Jenkins RB; Qian J; Lee HK; Huang H; Hirasawa K; Bostwick DG; Proffitt J; Wilber K; Lieber MM; Liu W; Smith DI
Cancer Res; 1998 Feb; 58(4):759-66. PubMed ID: 9485032
[TBL] [Abstract][Full Text] [Related]
20. Presence of two members of c-erbA receptor gene family (c-erbA beta and c-erbA2) in smallest region of somatic homozygosity on chromosome 3p21-p25 in human breast carcinoma.
Ali IU; Lidereau R; Callahan R
J Natl Cancer Inst; 1989 Dec; 81(23):1815-20. PubMed ID: 2573734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
